Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zimmer Biomet : JPMorgan Adjusts Price Target for Zimmer Biomet Holdings to $170 From $155, Maintains Neutral Rating

05/05/2021 | 09:29am EDT


ę MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
07:13aZIMMER BIOMET : Announces Second Quarter 2021 Financial Results (Form 8-K)
PU
06:48aZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition (fo..
AQ
06:47aZIMMER : Q2 Earnings Snapshot
AQ
06:43aZIMMER BIOMET : áBiometáAnnouncesáSecondáQuarterá2021áFinancial Results
PU
06:33aGUIDANCE : (ZBH) ZIMMER BIOMET HOLDINGS Sees Fiscal Year 2021 EPS Range $7.65 - ..
MT
06:33aZIMMER BIOMET : Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Reports Q2 EPS $1.90..
MT
06:33aZIMMER BIOMET : Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Posts Q2 Revenue $2...
MT
06:31aZIMMER BIOMET : Announces Second Quarter 2021 Financial Results
PR
07/15BACTIGUARD : Interim report for Q2 2021
AQ
07/06ZIMMER BIOMET : Announces Webcast and Conference Call of Second Quarter 2021 Fin..
PR
More news
Financials (USD)
Sales 2021 8 115 M - -
Net income 2021 1 063 M - -
Net Debt 2021 6 229 M - -
P/E ratio 2021 32,1x
Yield 2021 0,59%
Capitalization 33 985 M 33 985 M -
EV / Sales 2021 4,96x
EV / Sales 2022 4,53x
Nbr of Employees 20 000
Free-Float 66,7%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 31
Last Close Price 163,01 $
Average target price 190,46 $
Spread / Average Target 16,8%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.5.79%33 985
ABBOTT LABORATORIES10.49%214 853
MEDTRONIC PLC12.10%176 401
BECTON, DICKINSON AND COMPANY2.36%74 487
ALIGN TECHNOLOGY, INC.30.99%55 396
HOYA CORPORATION12.37%54 156